Skip to main navigation Skip to search Skip to main content

Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease

  • Hendrik Wesseling
  • , Waltraud Mair
  • , Mukesh Kumar
  • , Christoph N. Schlaffner
  • , Shaojun Tang
  • , Pieter Beerepoot
  • , Benoit Fatou
  • , Amanda J. Guise
  • , Long Cheng
  • , Shuko Takeda
  • , Jan Muntel
  • , Melissa S. Rotunno
  • , Simon Dujardin
  • , Peter Davies
  • , Kenneth S. Kosik
  • , Bruce L. Miller
  • , Sabina Berretta
  • , John C. Hedreen
  • , Lea T. Grinberg
  • , William W. Seeley
  • Bradley T. Hyman, Hanno Steen, Judith A. Steen*
*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

A high-resolution quantitative proteomics map of post-translational modifications on multiple isoforms of Tau shows heterogeneity across Alzheimer's disease patients, reflective of disease progression, and identifies critical targets at each stage of disease.
Original languageEnglish
Article numbere13
Pages (from-to)1699-1713
JournalCell
Volume183
Issue number6
Online published13 Nov 2020
DOIs
Publication statusPublished - 10 Dec 2020
Externally publishedYes

Research Keywords

  • absolute quantification
  • disease progression
  • FLEXITau
  • multiple reaction monitoring (MRM)
  • post-translational modifications
  • prion-like molecules
  • protein aggregation
  • proteomics
  • proteopathy
  • quantitative mass spectrometry

Fingerprint

Dive into the research topics of 'Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this